23rd Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)
Pre-Conference Workshop – Microsampling
Sponsored by New Objective
Enaksha Wickremsinhe, Eli Lilly & Co.
“Easy to understand unhealthy, how do we understand healthy?” – Enaksha Wickremsinhe, Eli Lilly & Co.
Microsampling in patients is already an established method, but how do we increase adoption and integrate into current workflows? Enaksha talks about how we are all patients, and that we all have or will ride the healthcare train. Our goal is to stay healthy, but often we only visit the doctor’s office when we are sick. Enaksha describes a world where microsampling plays an important role in describing health – possibly sampling at home – instead of only going to the clinic or doctor’s office when we are sick. Ubiquitously implementing these new processes using existing, mature technologies has gained momentum – but it has and does take a village to get it done.
23rd Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)
Pre-Conference Workshop – Microsampling
Sponsored by New Objective
Melanie Anderson, Merck
“Focus on the North Star, the patient” – Melanie Anderson, Merck
Melanie is focused on the patient and how to improve healthcare, through microsampling techniques and improved clinical trial data. With the onset of the pandemic, we have had to rethink the way we practice healthcare and clinical trials, especially those that are at high risk, i.e. sick children and oncology patients. Melanie suggests that we can improve patient care through remote sampling, alleviating the need to travel to a medical center – even long distances – to participate in clinical trials. As well, pharma makes decisions based on data, so improvements in data will lead to better decisions. With all of the technology that we have already, why do we think of and implement different ways to move forward with healthcare and clinical trials?
Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)
Pre-Conference Workshop – Microsampling
Sponsored by New Objective
Kevin Bateman, Merck
“The sharing part is important, it motivates others to do the same” – Kevin Bateman, Merck
The microsampling community continues to improve technologies and solutions for the patient, while working towards understanding human biology. During Kevin’s CPSA Everyday, Microsampling edition, he describes a Vison that is dedicated to motivating others to engage in microsampling – in a collaborative way. While working through the complexity of iterative loops for development of technology to solutions (from a perceived failure, to understanding, to improving the science or process) we can work together with each other’s expertise, for the patient. Each human is different, and such: Why can’t each human be their own control? Starting from a heal prick at birth, can we simply have more data points? Kevin discusses a Vision that also speaks towards patient adherence and regulatory aspects for implementing micosampling solutions. In the end, improving healthcare is not a competition, it is actually a team sport.
